- Home
- HOLO vs UNCY Comparison
HOLO vs UNCY Comparison
Compare HOLO & UNCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOLO
- UNCY
- Stock Information
- Founded
- HOLO 2018
- UNCY 2016
- Country
- HOLO China
- UNCY United States
- Employees
- HOLO N/A
- UNCY N/A
- Industry
- HOLO Computer Software: Programming Data Processing
- UNCY Biotechnology: Pharmaceutical Preparations
- Sector
- HOLO Technology
- UNCY Health Care
- Exchange
- HOLO Nasdaq
- UNCY Nasdaq
- Market Cap
- HOLO 66.4M
- UNCY 74.2M
- IPO Year
- HOLO N/A
- UNCY 2021
- Fundamental
- Price
- HOLO $3.64
- UNCY $4.46
- Analyst Decision
- HOLO
- UNCY Strong Buy
- Analyst Count
- HOLO 0
- UNCY 5
- Target Price
- HOLO N/A
- UNCY $41.60
- AVG Volume (30 Days)
- HOLO 1.1M
- UNCY 459.6K
- Earning Date
- HOLO 01-01-0001
- UNCY 11-14-2025
- Dividend Yield
- HOLO N/A
- UNCY N/A
- EPS Growth
- HOLO N/A
- UNCY N/A
- EPS
- HOLO 13.81
- UNCY N/A
- Revenue
- HOLO $44,840,587.00
- UNCY N/A
- Revenue This Year
- HOLO N/A
- UNCY N/A
- Revenue Next Year
- HOLO N/A
- UNCY $19,392.60
- P/E Ratio
- HOLO $0.29
- UNCY N/A
- Revenue Growth
- HOLO 37.10
- UNCY N/A
- 52 Week Low
- HOLO $3.46
- UNCY $3.71
- 52 Week High
- HOLO $370.00
- UNCY $11.00
- Technical
- Relative Strength Index (RSI)
- HOLO 35.24
- UNCY 44.70
- Support Level
- HOLO $3.83
- UNCY $4.32
- Resistance Level
- HOLO $4.54
- UNCY $5.39
- Average True Range (ATR)
- HOLO 0.33
- UNCY 0.30
- MACD
- HOLO -0.06
- UNCY -0.07
- Stochastic Oscillator
- HOLO 10.53
- UNCY 12.14
About HOLO MicroCloud Hologram Inc.
MicroCloud Hologram Inc, through its subsidiaries, is mainly engaged in holographic Technology. It includes Holographic solutions and Holographic technology services. The company also provides holographic digital twin technology services for customers and has built a holographic digital twin technology resource library. Geographically company is operating in single segment, China.
About UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.